Cargando…

Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis

AIMS: Outcomes of current operative treatments for arthrofibrosis after total knee arthroplasty (TKA) are not consistently positive or predictable. Pharmacological in vivo studies have focused mostly on prevention of arthrofibrosis. This study used a rabbit model to evaluate intra-articular (IA) eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Trousdale, William H., Limberg, Afton K., Reina, Nicolas, Salib, Christopher G., Thaler, Roman, Dudakovic, Amel, Berry, Daniel J., Morrey, Mark E., Sanchez-Sotelo, Joaquin, van Wijnen, Andre, Abdel, Matthew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801169/
https://www.ncbi.nlm.nih.gov/pubmed/35084209
http://dx.doi.org/10.1302/2046-3758.111.BJR-2021-0546.R1
_version_ 1784642395060568064
author Trousdale, William H.
Limberg, Afton K.
Reina, Nicolas
Salib, Christopher G.
Thaler, Roman
Dudakovic, Amel
Berry, Daniel J.
Morrey, Mark E.
Sanchez-Sotelo, Joaquin
van Wijnen, Andre
Abdel, Matthew P.
author_facet Trousdale, William H.
Limberg, Afton K.
Reina, Nicolas
Salib, Christopher G.
Thaler, Roman
Dudakovic, Amel
Berry, Daniel J.
Morrey, Mark E.
Sanchez-Sotelo, Joaquin
van Wijnen, Andre
Abdel, Matthew P.
author_sort Trousdale, William H.
collection PubMed
description AIMS: Outcomes of current operative treatments for arthrofibrosis after total knee arthroplasty (TKA) are not consistently positive or predictable. Pharmacological in vivo studies have focused mostly on prevention of arthrofibrosis. This study used a rabbit model to evaluate intra-articular (IA) effects of celecoxib in treating contracted knees alone, or in combination with capsular release. METHODS: A total of 24 rabbits underwent contracture-forming surgery with knee immobilization followed by remobilization surgery at eight weeks. At remobilization, one cohort underwent capsular release (n = 12), while the other cohort did not (n = 12). Both groups were divided into two subcohorts (n = 6 each) – one receiving IA injections of celecoxib, and the other receiving injections of vehicle solution (injections every day for two weeks after remobilization). Passive extension angle (PEA) was assessed in live rabbits at 10, 16, and 24 weeks, and disarticulated limbs were analyzed for capsular stiffness at 24 weeks. RESULTS: IA celecoxib resulted in greater mean PEA at ten weeks (69.6° (SD 4.6) vs 45.2° (SD 9.6), p = 0.004), 16 weeks (109.8° (SD 24.2) vs 60.9° (SD10.9), p = 0.004), and 24 weeks (101.0° (SD 8.0) vs 66.3° (SD 5.8), p = 0.004). Capsular stiffness was significantly reduced with IA celecoxib (2.72 Newton per cm (N·cm)/° (SD 1.04), p = 0.008), capsular release (2.41 N·cm/° (SD 0.80), p = 0.008), and capsular release combined with IA celecoxib (3.56 N·cm/° (SD 0.99), p = 0.018) relative to IA vehicle (6.09 N·cm/° (SD 1.64)). CONCLUSION: IA injections of a celecoxib led to significant improvements in passive extension angles, with reduced capsular stiffness, when administered to rabbit knees with established experimental contracture. Celecoxib was superior to surgical release, and the combination of celecoxib and a surgical release did not provide any additional value. Cite this article: Bone Joint Res 2022;11(1):32–39.
format Online
Article
Text
id pubmed-8801169
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Editorial Society of Bone & Joint Surgery
record_format MEDLINE/PubMed
spelling pubmed-88011692022-02-22 Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis Trousdale, William H. Limberg, Afton K. Reina, Nicolas Salib, Christopher G. Thaler, Roman Dudakovic, Amel Berry, Daniel J. Morrey, Mark E. Sanchez-Sotelo, Joaquin van Wijnen, Andre Abdel, Matthew P. Bone Joint Res Knee AIMS: Outcomes of current operative treatments for arthrofibrosis after total knee arthroplasty (TKA) are not consistently positive or predictable. Pharmacological in vivo studies have focused mostly on prevention of arthrofibrosis. This study used a rabbit model to evaluate intra-articular (IA) effects of celecoxib in treating contracted knees alone, or in combination with capsular release. METHODS: A total of 24 rabbits underwent contracture-forming surgery with knee immobilization followed by remobilization surgery at eight weeks. At remobilization, one cohort underwent capsular release (n = 12), while the other cohort did not (n = 12). Both groups were divided into two subcohorts (n = 6 each) – one receiving IA injections of celecoxib, and the other receiving injections of vehicle solution (injections every day for two weeks after remobilization). Passive extension angle (PEA) was assessed in live rabbits at 10, 16, and 24 weeks, and disarticulated limbs were analyzed for capsular stiffness at 24 weeks. RESULTS: IA celecoxib resulted in greater mean PEA at ten weeks (69.6° (SD 4.6) vs 45.2° (SD 9.6), p = 0.004), 16 weeks (109.8° (SD 24.2) vs 60.9° (SD10.9), p = 0.004), and 24 weeks (101.0° (SD 8.0) vs 66.3° (SD 5.8), p = 0.004). Capsular stiffness was significantly reduced with IA celecoxib (2.72 Newton per cm (N·cm)/° (SD 1.04), p = 0.008), capsular release (2.41 N·cm/° (SD 0.80), p = 0.008), and capsular release combined with IA celecoxib (3.56 N·cm/° (SD 0.99), p = 0.018) relative to IA vehicle (6.09 N·cm/° (SD 1.64)). CONCLUSION: IA injections of a celecoxib led to significant improvements in passive extension angles, with reduced capsular stiffness, when administered to rabbit knees with established experimental contracture. Celecoxib was superior to surgical release, and the combination of celecoxib and a surgical release did not provide any additional value. Cite this article: Bone Joint Res 2022;11(1):32–39. The British Editorial Society of Bone & Joint Surgery 2022-01-27 /pmc/articles/PMC8801169/ /pubmed/35084209 http://dx.doi.org/10.1302/2046-3758.111.BJR-2021-0546.R1 Text en © 2022 Author(s) et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Knee
Trousdale, William H.
Limberg, Afton K.
Reina, Nicolas
Salib, Christopher G.
Thaler, Roman
Dudakovic, Amel
Berry, Daniel J.
Morrey, Mark E.
Sanchez-Sotelo, Joaquin
van Wijnen, Andre
Abdel, Matthew P.
Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
title Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
title_full Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
title_fullStr Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
title_full_unstemmed Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
title_short Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
title_sort intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
topic Knee
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801169/
https://www.ncbi.nlm.nih.gov/pubmed/35084209
http://dx.doi.org/10.1302/2046-3758.111.BJR-2021-0546.R1
work_keys_str_mv AT trousdalewilliamh intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT limbergaftonk intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT reinanicolas intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT salibchristopherg intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT thalerroman intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT dudakovicamel intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT berrydanielj intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT morreymarke intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT sanchezsotelojoaquin intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT vanwijnenandre intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis
AT abdelmatthewp intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis